Clinical Trial Update: A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy

View source ↗

Summary

A pharmacokinetic and pharmacogenetic study is being conducted in patients treated with sulfamethoxazole-trimethoprim for Pneumocystis jirovecii pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pneumocystis Jirovecii Pneumonia | Status: UNKNOWN